undamentalytics Newsletter
Sign in

Pacific Biosciences Of California, Inc. balance sheet

At the end of fiscal 2025, Pacific Biosciences Of California, Inc. had total assets of $784m, total liabilities of $779m and shareholders' equity of $5.3m. It held $63.7m in cash against $645m of debt: net debt of $582m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents8914859472636341717193082461325180556461
Receivables—053335111391517241937283531
Inventory—716101011111623181314255057594961
Total current assets—293200115126118111109102132813561,101852742496375339
Goodwill————————————410410462318318318
Total assets—3062181301361241311381441701484142,0071,7671,7461,260784752
Accounts payable—105326589784111215172119
Deferred revenue (current)—343—————789113016141616
Total current liabilities—21191523313834292749397226395667369
Short-term debt—000————————2200——
Long-term debt—33313141516141516—896897892647645644
Total debt033313141516141532—900900893647645644
Total liabilities—26272067695853585693781,2161,2041,045754779785
Shareholders' equity−1772801911096955748586114553357915637015075−33
Net debt (negative = net cash)−89−145−56−44−13−22−19−1−3−42−82439575713592582583
Shares outstanding——55m56m66m74m80m93m116m150m153m192m221m227m268m294m302m311m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: GRAL vs PACBPACB vs QTRXCYRX vs PACB

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Pacific Biosciences Of California, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pacific Biosciences Of California, Inc.